Aardvark therapeutics to present at upcoming investor conferences in september

San diego, aug. 27, 2025 (globe newswire) -- aardvark therapeutics, inc. (aardvark) (nasdaq: aard), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, announced that it will present at the following conferences during september:
AARD Ratings Summary
AARD Quant Ranking